Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.

@article{AuwHaedrich2001LongTO,
  title={Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.},
  author={Claudia Auw-Haedrich and Sarah E Coupland and Alexander Kapp and Annette Schmitt-Graeff and Renate Buchen and Heinrich Witschel},
  journal={The British journal of ophthalmology},
  year={2001},
  volume={85 1},
  pages={63-9}
}
AIM To classify ocular adnexal lymphomas according to the Revised European and American Lymphoma (REAL) classification and to determine any correlation between clinical features or histomorphological variables with the patients' outcome. METHODS Conventional and immunohistology were performed on representative sections of 53 specimens of 46 patients with ocular adnexal lymphoma. The antibodies used were CD20, BCL-2, CD21, CD23, CD43, CD3, CD5, p53, cyclin D1, pan-cytokeratin, kappa, lambda… CONTINUE READING